THE BOARD OF DIRECTORS OF THAT MAN MAY SEE, MELLON AND CANAAN PARTNERS



EYE OPENERS: BIOENGINEERING VISION BREAKTHROUGHS

Tuesday, June 20, 2006

A breakfast for venture capitalists and entrepreneurial individuals

At Canaan Partners

2765 Sand Hill Road

Menlo Park, CA 94025

Featuring faculty members from UCSF's Department of Ophthalmology:

Eugene de Juan, Jr., MD, and Jacque Duncan, MD


The Eye Opener series creates a dialogue

among UCSF faculty with individual and

corporate partners intended to drive

technology from inception to patient care.
Drs. de Juan and Duncan will share

early-stage translational research aimed

at new medical products, treatments,

and procedures – especially related to

retinal diseases including macular

degeneration and retinitis pigmentosa.

Breakfast and program will begin at 7:30 a.m. and conclude by 9:00 a.m.

To make a reservation, contact That Man May See

at 415.476.4016 or tmms@vision.ucsf.edu.

(Limited seating)

For Directions: 650.854.8092 | www.canaan.com


EUGENE DE JUAN, JR., MD
Jean Kelly Stock Distinguished
Professor of Ophthalmology

Dr. de Juan is President of the American Society of Retinal Specialists, and has held all major officer positions in the society. Dr. de Juan has made prodigious contributions to his areas of major research that include severe vitreoretinal disease, retinitis pigmentosa, macular degeneration, and vitreoretinal surgical instrument development. He has published over 200 scholarly, peer-reviewed journal articles and amassed more than 40 issued patents.

Prior to joining the UCSF faculty, Dr. de Juan was the Joseph E. Green Professor of Ophthalmology Inaugural Chair at the Wilmer Eye Institute of the Johns Hopkins University, and the Chief Executive Officer of the Doheny Retina Institute of the University of Southern California.


JACQUE L. DUNCAN, MD
Associate Professor of Ophthalmology

Dr. Duncan’s clinical emphasis is diagnosis, electrophysiologic evaluation, and management of patients with retinal degenerative disease, including age-related macular degeneration, retinitis pigmentosa, cone rod dystrophy, and Stargardt macular dystrophy.

Her research includes characterization of retinal degenerations using novel imaging techniques in patients, as well as preclinical evaluation of therapies for inherited retinal degenerations.